secwatch / observer
8-K filed May 16, 2024, 7:59 PM ET ticker MTH CIK 0000833079
other material confidence high sentiment neutral materiality 0.15

Meritage shareholders approve proposal to elect directors annually; board nominees elected

Meritage Homes CORP

item 5.07item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0000833079-24-000082
form_type
8-K
ticker
MTH
cik
0000833079
company_name
Meritage Homes CORP
filed_at
2024-05-16T23:59:59+00:00
discovered_at
2026-05-14T18:03:22.107184+00:00
generated_at
2026-06-01T22:13:51.965027+00:00
sec_items
["5.07", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.25
calibrated_materiality_score
0.15
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0000833079-24-000082
json_url
https://secwatch.observer/filing/0000833079-24-000082.json
markdown_url
https://secwatch.observer/filing/0000833079-24-000082.md
text_url
https://secwatch.observer/filing/0000833079-24-000082.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/833079/000083307924000082/0000833079-24-000082-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/833079/000083307924000082/mth-20240516.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

1dbb0721056f27f0a19d1c9afa9b04edcdeccc8b

Meritage Homes CORP shareholders approved Advisory vote to approve compensation of named executive officers at the 2024-05-16 meeting.

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers by the votes set forth in the table below.

SEC 8-K Item 5.07 confidence 0.99 SEC evidence

6eed4d93d1f08622f567c05a029020c3811f837f

Meritage Homes CORP shareholders approved Stockholder proposal to elect each director annually at the 2024-05-16 meeting.

The Company’s stockholders approved, as set forth below, a stockholder proposal to elect each director annually.

SEC 8-K Item 5.07 confidence 0.98 SEC evidence

c4101f243f6c157b70a7d8dbfccc18c72ab855e9

Meritage Homes CORP shareholders approved Election of five Class I Directors and one Class II Director at the 2024-05-16 meeting.

The Company’s stockholders elected five individuals to the Board of Directors as Class I Directors and one individual as a Class II Director by the votes set forth in the table below.

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

f048756445565cb18bba51358360e7108be5c2cb

Meritage Homes CORP shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered accounting firm for 2024 at the 2024-05-16 meeting.

The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered accounting firm for the 2024 fiscal year by the votes set forth in the table below.

SEC 8-K Item 5.07 confidence 0.99 SEC evidence

Comparable filings

DUOT

Duos Tech annual meeting: all five director nominees elected, auditor ratified

DUOS TECHNOLOGIES GROUP, INC. June 2, 2026, 8:30 AM ET other_material Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers by the votes set forth in the table below.

Comparable filing

Proposal No. 4 : To elect Frank D. Recker, Chief Executive Officer of the Company, to serve as a member of the board of directors and to hold office for a one-year term and until his successor is elected and qualified. Votes For Votes With held Frank D. Recker 13,959,958 2,064,009

Filing page SEC filing

MPT

MPT shareholders elect all directors, approve say-on-pay and equity plan with notable opposition

MEDICAL PROPERTIES TRUST INC June 1, 2026, 4:55 PM ET other_material Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers by the votes set forth in the table below.

Comparable filing

Proposal 2: The ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026: For: Against: Abstensions: Broker Non-Votes: 459,883,831 6,189,396 2,613,330 —

Filing page SEC filing

LODE

Comstock holds AGM; all director nominees elected, auditor and equity plan approved

Comstock Inc. June 1, 2026, 4:15 PM ET other_material Items 5.07, 7.01, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers by the votes set forth in the table below.

Comparable filing

4. Vote on Comstock Inc. 2026 Equity Incentive Plan. The stockholders approved the Comstock Inc. 2026 Equity Incentive Plan as set forth below. Voted For Voted Against Abstain Broker Non-Votes 25,069,375 1,393,479 1,194,028 21,410,649

Filing page SEC filing

LINC

Annual meeting votes pass; strategic plan presentation attached but content not disclosed

LINCOLN EDUCATIONAL SERVICES CORP May 11, 2026, 7:59 PM ET other_material Items 5.07, 7.01, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers by the votes set forth in the table below.

Comparable filing

Proposal Number 1 : To elect the following 10 individuals named in the Company’s proxy statement as directors of the Company for a one-year term which will expire at the 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified. Each nominee for director was elected by a vote of the shareholders as follows: Nominee Votes For Votes Withheld Broker Non-Votes John A Bartholdson 23,626,016 239,935 3,137,471 James J. Burke, Jr. 23,575,182 290,769 3,137,471 Anna Escobedo Cabral 23,599,841 266,110 3,137,471 Kevin M. Carney 23,628,321 237,630 3,137,471 Marta Newhart 23,615,050 250,901 3,137,471 Michael A Plater 23,479,505 386,446 3,137,471 Felecia J. Pryor 23,612,578 253,373 3,137,471 Carlton E. Rose 23,629,625 236,326 3,137,471 Scott M. Shaw 23,647,094 218,857 3,137,471 Sylvia J. Young 23,631,057 234,894 3,137,471

Filing page SEC filing

MRNA

Moderna amends bylaws for federal forum exclusivity; stockholders re-elect directors

Moderna, Inc. May 11, 2026, 7:59 PM ET other_material Items 5.03, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers by the votes set forth in the table below.

Comparable filing

The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026, with the votes cast as follows:

Filing page SEC filing

PCT

PureCycle shareholders elect all nine directors, ratify auditor, approve say-on-pay at 2026 annual meeting

PureCycle Technologies, Inc. May 11, 2026, 7:59 PM ET other_material Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers by the votes set forth in the table below.

Comparable filing

Proposal 2 – Ratify the appointment of Grant Thornton, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Abstain Broker Non Vote 127,904,943 406,709 196,157 0

Filing page SEC filing

TKR

Timken enters retention agreement with EVP Hansal Patel through June 2028

TIMKEN CO May 8, 2026, 7:59 PM ET other_material Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers by the votes set forth in the table below.

Comparable filing

(3) ratified the appointment of Ernst & Young LLP as its independent auditor for the fiscal year ending December 31, 2026; and FOR AGAINST ABSTAIN BROKER NON-VOTES 61,717,389 1,977,231 35,539 0

Filing page SEC filing

CYTK

Cytokinetics director Smith resigns; stockholders approve 300K-share ESPP increase

CYTOKINETICS INC May 17, 2024, 7:59 PM ET other_material Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers by the votes set forth in the table below.

Comparable filing

Proposal 2: Approval of the Amendment and Restatement of the Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of shares authorized for issuance under such plan by 300,000 shares of common stock. The stockholders approved the Amendment and Restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of shares authorized for issuance under such plan by 300,000 shares of common stock. The votes were as follows: For Against Abstain Broker Non-Vote 88,586,473 481,098 464,524 6,649,555

Filing page SEC filing

Source: SEC EDGAR
accession 0000833079-24-000082
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.